NASDAQ · Medical - Healthcare Information Services

EUDA Health Holdings Limited (EUDA) Stock

$18.25 +21.75% NASDAQ: EUDA Healthcare

EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns.

Valuation

MetricValue
Price$18.25
Market Cap$34.08M
P/E Ratio-10.07
P/B Ratio-6.61
P/S Ratio4.10
EPS (TTM)$-1.49
52-Week High$86.00
52-Week Low$5.26
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE69.63%
ROA-161.53%
ROCE60.16%
Gross Margin-28.57%
Operating Margin-28.57%
Net Margin-40.65%
Debt/Equity-0.56
Current Ratio0.17

Annual Financials (USD)

Metric20212022202320242025
Revenue$5.0M$4.0M$4.0M$4.0M$7.0M
Operating Profit$-1.0M$-6.0M$-4.0M$-17.0M$-2.0M
Net Profit$1.0M$-25.0M$-10.0M$-15.0M$-3.0M
EPS$1.87$-41.40$-8.80$-9.40$-1.49
Op Margin-12.3%-151.9%-106.9%-432.2%-35.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$8.0M$26.0M$1.0M$2.0M$2.0M
Total Liabilities$7.0M$29.0M$9.0M$4.0M$6.0M
Cash$0$0$0$0$0
Borrowings$0$4.0M$3.0M$1.0M$2.0M

Latest News

EUDA Health Regains Nasdaq Minimum Market Value Compliance, Expands Product Line MT Newswires · Jun 1, 2026 EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask GlobeNewswire · Jun 1, 2026 EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency GlobeNewswire · Jun 1, 2026 EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development GlobeNewswire · Apr 28, 2026 EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities GlobeNewswire · Apr 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-2.0M$-3.0M$-2.0M$-2.0M
Investing Cash Flow$-1.0M$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$1.0M$-1.0M$0$0
Free Cash Flow$0$-2.0M$-3.0M$-2.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.13
EV / EBITDA-16.79
FCF Yield-8.80%
Quick Ratio0.17
Interest Coverage-56.76
Return 1Y-81.51%
Return 3Y-6.66%
Return 5Y—

Ownership

Insiders Held49.42%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Geode Capital Management, LLC1,0332025-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADVMAdverum Biotechnologies, Inc. $4.36 +0.00% -0.66 $96.26M 0.00%
AMWL $10.87 +0.88% -1.32 $181.54M 0.00%
ATYR $0.49 +1.19% -0.72 $47.62M 0.00%
DTIL $7.00 +1.60% -1.97 $89.80M 0.00%
FONR $19.09 +0.00% 15.33 $117.76M 0.00%

About EUDA Health Holdings Limited

EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited.

EUDA Health Holdings Limited is led by CEO Alfred Lim, employs 117 people, headquartered in SG, publicly traded since 2021.

EUDA Health Holdings Limited (EUDA) stock trades at $18.25 with a market capitalization of $34.08M. The stock is valued at a price-to-earnings (P/E) ratio of -10.07, price-to-book of -6.61, price-to-sales of 4.10. Over the past 52 weeks the stock has ranged between $5.26 and $86.00, and currently trades 78.8% below its 52-week high.

On profitability, EUDA Health Holdings Limited generates a return on equity (ROE) of 69.63% — well above the market average, a sign of a high-quality business, return on capital employed of 60.16%, an operating margin of -28.57%, a net profit margin of -40.65%.

Official website: euda.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides